4-Methylcyclohexylamine Hydrochloride | CAS:100959-19-1

We serve 4-Methylcyclohexylamine Hydrochloride CAS:100959-19-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Methylcyclohexylamine Hydrochloride

Chemical Name:4-Methylcyclohexylamine Hydrochloride
CAS.NO:100959-19-1
Synonyms:4-Methylcyclohexylamine Hydrochloride
Hexahydro-p-toluidine Hydrochloride
trans-4-Methylcyclohexanamine hydrochloride
 
Physical and Chemical Properties:
Boiling Point 195.9ºC at 760 mmHg
Melting Point 224ºC (dec.)
Molecular Formula C7H16ClN
Molecular Weight 149.662
Flash Point 72.3ºC
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Isomer:≤0.5%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Glimepiride(CAS:93479-97-1).



Contact us for information like 4-Methylcyclohexylamine Hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,trans-4-Methylcyclohexanamine hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Hexahydro-p-toluidine Hydrochloride Use and application,Hexahydro-p-toluidine Hydrochloride technical grade,usp/ep/jp grade.


Related News: As of Friday, the virus had claimed the lives of more than 250 people in mainland China.2-[[1,3-dioxo-1-[(2-oxo-1,3-dihydrobenzimidazol-5-yl)amino]butan-2-yl]diazenyl]benzoic acid manufacturer As of Friday, the virus had claimed the lives of more than 250 people in mainland China.2-Bromo-6-nitrophenol supplier Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.3',5'-Bis-O-(4-chlorobenzoyl)-2-deoxy-5-azacytosine vendor Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.